ENVALITH
森永製菓株式会社 logo

Morinaga & Co.,Ltd.

2201Prime MarketFoods

森永製菓株式会社 logo
Morinaga & Co.,Ltd.2201

Food Manufacturing

Morinaga & Co. Group's core segment, manufacturing and selling confectionery, frozen desserts, and jelly drinks, etc.

PeriodCurrentPreviousChange
Segment revenue (external customers)¥225,167 million¥217,578 million
Segment profit¥22,327 million¥19,862 million
Segment assets¥188,993 million¥163,705 million
Depreciation and amortization¥9,924 million¥9,667 million
Increase in property, plant and equipment and intangible assets¥5,776 million¥10,526 million
Domestic sales total¥194,466 million¥187,562 million
Overseas sales total¥30,700 million¥30,016 million

Business Details

Comprised of the Confectionery and Foods business (Hi-Chew, Chocoball, Morinaga Biscuits, etc.), the Frozen Desserts business (Vanilla Monaka Jumbo, chocolate-coated ice cream bars, etc.), the in business (in Jelly, in Bar), the mail-order business (Oishii Collagen Drink), operating subsidiaries (Anthelier Co., Ltd., etc.), the U.S. business (HI-CHEW), and China/Taiwan/exports, etc. This is the company's core segment, providing confectionery, food, and health food products to consumers domestically and internationally, and accounts for approximately 95% of consolidated net sales.

Recent Overview

Confectionery and Foods and Frozen Desserts posted substantial profit growth from price revision effects, while the U.S. business saw a sharp profit decline due to intensifying competition and tariff impacts

In the Food Manufacturing segment for FY2026 (ending March 2026), net sales were ¥225,167 million (up 3.5% year on year) and segment profit was ¥22,327 million (up 12.4% year on year). In the Confectionery and Foods business, the effects of price revisions and cost reductions became apparent, and operating profit expanded sharply to ¥8,163 million, up 108.4% year on year. The Frozen Desserts business also posted a 16.5% increase in profit on the strength of core products. On the other hand, the U.S. business deteriorated substantially, with operating profit falling 57.3% to ¥1,310 million, due to a combination of sluggish consumption from inflation, intensifying competition with major confectionery makers, the impact of U.S. tariff policy, and increased promotional expenses. The in business also saw profit decline 19.3% due to weak performance of its core products. As a subsequent event, on April 1, 2026, the company made MyMo Holdco, Inc. (the largest mochi ice cream manufacturer in the United States) a subsidiary at an acquisition cost of ¥20,849 million, aiming to acquire a value chain in the U.S. frozen desserts business.

Key Products

product
Confectionery and Foods business

Offers Morinaga Biscuits, Hi-Chew, Morinaga Ramune, Carre de Chocolat, Dars, Chocoball, Morinaga Cocoa, Morinaga Amazake, and others. Net sales for FY2026 (ending March 2026) were ¥88,957 million (up 5.4% year on year), and operating profit was ¥8,163 million (up 108.4% year on year). The effects of multiple price revisions and strong performance of core brands substantially improved profitability.

product
Frozen Desserts business

Offers Vanilla Monaka Jumbo, chocolate-coated ice cream bars (including macadamia), The Crepe, Ice Box, and others. Net sales for FY2026 (ending March 2026) were ¥53,528 million (up 8.4% year on year), and operating profit was ¥4,963 million (up 16.5% year on year). Strong performance of core products continued even after the September price revision, achieving higher sales and profit.

product
in business

Offers in Jelly (Energy, Energy Grape Sugar, etc.) and in Bar (protein bars and nutritionally balanced foods). Net sales for FY2026 (ending March 2026) were ¥29,955 million (down 4.4% year on year), and operating profit was ¥5,888 million (down 19.3% year on year). Weak performance of core products and increased logistics costs contributed to the only decline in sales and profit among priority areas.

service
Mail-order business

Offers Oishii Collagen Drink, Oishii Aojiru, and others via mail order. Net sales for FY2026 (ending March 2026) were ¥10,748 million (down 3.9% year on year). Sales declined due to growing frugality among consumers and cancellations following price revisions, but operating profit improved substantially to ¥7,114 million (up 49.4% year on year) through more efficient advertising investment.

service
Operating subsidiaries, etc.

Comprised of Anthelier Co., Ltd. (manufacture and sale of Western confectionery), Morinaga Ichiba Kaihatsu Co., Ltd. (theme park and antenna shop sales), and others. Net sales for FY2026 (ending March 2026) were ¥11,276 million (up 0.3% year on year), and operating profit was ¥718 million (up 106.9% year on year). Theme park and antenna shop sales at Morinaga Ichiba Kaihatsu Co., Ltd. performed well.

product
U.S. business (HI-CHEW)

HI-CHEW is sold at U.S. food supermarkets, convenience stores, and other outlets. The jelly drink Chargel is also being developed. Net sales for FY2026 (ending March 2026) were ¥20,214 million (down 3.5% year on year), and operating profit was ¥1,310 million (down 57.3% year on year). Sluggish consumption due to inflation, intensifying competition, the impact of U.S. tariff policy, and increased promotional expenses combined to cause a substantial decline in profit.

product
China, Taiwan, exports, etc.

In China, HI-CHEW performed well in both store and online sales; in Taiwan, in Jelly and HI-CHEW remained solid. Global expansion of HI-CHEW is also being pursued in East Asia, Southeast Asia, Oceania, and Europe. Net sales for FY2026 (ending March 2026) were ¥10,486 million (up 15.7% year on year), and operating profit was ¥569 million (up 14.7% year on year).

Growth Drivers

  • Penetration of the effects of multiple price revisions in the Confectionery and Foods business, and strong sales of core brands (Morinaga Ramune up 126% year on year, Carre de Chocolat up 113%, Chocoball up 111%, Morinaga Biscuits up 101%)
  • Continued strong performance of core products in the Frozen Desserts business (The Crepe up 121% year on year, Ice Box up 113%, Jumbo group up 105%, chocolate-coated ice cream bars up 104%) and price revision effects
  • Acquisition of MyMo Holdco, Inc. (the largest mochi ice cream manufacturer in the United States) as a subsidiary, gaining a U.S. frozen desserts value chain and expanding the overseas sales ratio (forecast at 17.4% in FY2027 (ending March 2027))
  • Expansion of the HI-CHEW global brand in China, Taiwan, exports, etc. (up 15.7% year on year) and accelerated expansion into Southeast Asia and Europe
  • Continued strong performance of Carre de Chocolat's "Cacao 70" amid growing demand for high-cacao health products, and growth of Morinaga Cocoa (up 119% year on year) as a health brand
  • Improved profitability in the mail-order business through more efficient advertising investment (operating profit up 49.4% year on year)

Risks

  • Soaring raw material prices such as cacao and sugar (projected to be a profit-reducing factor of approximately ¥15,900 million from raw material-related costs in the FY2027 (ending March 2027) forecast) and increased logistics costs (a profit-reducing factor of approximately ¥5,600 million)
  • Further intensification of the competitive environment in the U.S. business (entry of major confectionery makers into the candy category) and the continued impact of U.S. tariff policy (U.S. business operating profit forecast to decline 69.5% year on year to approximately ¥400 million in the FY2027 (ending March 2027) forecast)
  • Uncertainty regarding goodwill and purchase price allocation associated with the acquisition of MyMo Holdco, Inc. (acquisition cost of ¥20,849 million, goodwill amount not yet finalized) and integration risk
  • Declining demand in the in business and mail-order business due to consumers' growing frugality amid rising prices (in business down 4.4% year on year, mail-order business down 3.9% year on year)
  • Increased financial burden and higher depreciation expenses (forecast at ¥12,186 million in FY2027 (ending March 2027)) from large-scale capital investment, including construction of a second U.S. plant (forecast capital expenditure of ¥27,120 million in FY2027 (ending March 2027))
  • Risk of delayed market penetration and declining sales volume following price revisions, and risk of consumer attrition should further price revisions be implemented

Last updated: June 25, 2026